In our findings, the level of Aβ and BACE-1 in the Aβ1–42-mouse model of AD was significantly reduced with the administration of lupeol, as shown by the western blot and immunofluorescence analysis (Figure 2a,b). The gene discussed is BACE1; the disease is Alzheimer disease.